Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1994-6-30
|
pubmed:abstractText |
One hundred twenty-eight patients with myocardial infarction who underwent operation for myocardial revascularization and 147 patients who received medical therapy were followed up for up to 6 years: all patients had received treatment with intravenous streptokinase. In the surgical group, 91.5% of the patients had the region related to the infarction revascularized, and in 82.8% of them the mammary artery was used. Statistically significant differences were not detected between the groups according to infarct size, clinical features, and left ventricular ejection fraction. However, there was a higher risk in the surgical group, as compared with that in the medical group, in terms of anatomic characteristics: 99.2% versus 77.1% of the patients showed more than 70% residual obstruction at the "culprit" coronary artery (p < 0.001, 95% confidence interval 14.1% to 30.1%) and 76.8% versus 40.7% showed multivessel coronary disease (p < 0.001, 95% confidence interval 23.7% to 48.5%). In-hospital survival was 95.3% in the surgical group and 89.1% in the medical group (p = 0.096, 95% confidence interval -0.2% to 12.6%). Significantly higher survivals were obtained for the surgical group both during the first (93% +/- 2.3% versus 80.3% +/- 3.3%, p = 0.005) and the sixth (86.4% +/- 3.4% versus 68.4% +/- 4.3%, p = 0.003) year of follow-up. Statistically significant differences were also obtained when in-hospital deaths were excluded. A Cox regression model with 13 variables showed that only age (p = 0.0422) and medical treatment (p = 0.0194) correlated independently with mortality. It is concluded that in this nonrandomized study, operation led to a significantly higher survival both on a medium- and long-term basis, when compared with that obtained for patients receiving medical therapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0022-5223
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
107
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1454-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8196387-Actuarial Analysis,
pubmed-meshheading:8196387-Female,
pubmed-meshheading:8196387-Hospital Mortality,
pubmed-meshheading:8196387-Humans,
pubmed-meshheading:8196387-Male,
pubmed-meshheading:8196387-Middle Aged,
pubmed-meshheading:8196387-Myocardial Infarction,
pubmed-meshheading:8196387-Myocardial Revascularization,
pubmed-meshheading:8196387-Prospective Studies,
pubmed-meshheading:8196387-Regression Analysis,
pubmed-meshheading:8196387-Streptokinase,
pubmed-meshheading:8196387-Survival Analysis,
pubmed-meshheading:8196387-Thrombolytic Therapy,
pubmed-meshheading:8196387-Treatment Outcome
|
pubmed:year |
1994
|
pubmed:articleTitle |
Surgical revascularization after fibrinolysis in acute myocardial infarction. Long-term follow-up.
|
pubmed:affiliation |
Instituto de Moléstias Cardiovasculares, São José do Rio Preto, Brazil.
|
pubmed:publicationType |
Journal Article
|